A new study published in STAT News suggests the shingles vaccine may offer a protective benefit against dementia. Researchers found that nursing home residents who received at least one dose were 24 percent less likely to develop the condition.
The findings add to a growing body of evidence linking adult vaccinations to neurological health. While the mechanism remains unclear, scientists hypothesize that preventing shingles—a painful viral reactivation—may reduce neuroinflammation that contributes to cognitive decline.
The study analyzed health records from thousands of elderly residents, adjusting for age, sex, and underlying conditions. The 24 percent risk reduction was statistically significant, though the absolute risk difference was not detailed in the source.
Experts caution that these observational results do not prove causation. Clinical trials would be needed to confirm whether the vaccine directly prevents dementia or if vaccinated individuals simply engage in healthier behaviors overall.
"This is promising but preliminary," one geriatrician noted, emphasizing that other established dementia prevention strategies—like exercise and blood pressure control—remain more proven.